Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Did PROTEUS just change Urology?? cover art

Did PROTEUS just change Urology??

Did PROTEUS just change Urology??

Listen for free

View show details
About this listen

Breaking News podcast just after the long-awaited PROTEUS trial reads out at the ASCO Plenary in Chicago! Plus a simultaneous NEJM paper! Huge day for prostate cancer surgery.
Declan and Renu are joined by lead author Dr Mary-Ellen Taplin (Dana Farber Cancer Institute & Harvard University), to tell us about her decades long journey to this huge moment today. PROTEUS is a huge (2,100 men) phase III RCT of men undergoing radical prostatectomy for high-risk prostate cancer, randomised to receive peri-operative ADT + placebo, or ADT plus apalutamide. Mary-Ellen talks to us about the top-line results, and we consider whether this is truly a practice-changing study. Declan also had the honour of being the Discussant at teh ASCO Plenary so he is well placed to give his opinion.
Your usual hosts are Declan Murphy & Renu Eapen.

Even better on our YouTube channel

This is a Themed Podcast supported by our Gold Partner, Johnson & Johnson.


Links:

PROTEUS NEJM paper

adbl_web_anon_alc_button_suppression_t1
No reviews yet